JPRN-UMIN000046037已完成未知
Evaluation for topical use of ripasudil as ophthalmic solution. - Evaluation for topical use of ripasudil as ophthalmic solution.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
The mean endothelial cell density loss 90 to 120 days after surgery, excluding bullous keratopathy patients for whom measurements were not possible was -4.5% in the ripasudil group, which was significantly lower than in control group
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 110years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •With active ocular surface disease
研究者
相似试验
招募中
不适用
Effect of ripasudil on corneal endothelial damage after glaucoma tube shunt surgeryglaucomaJPRN-UMIN000042504Hiroshima University Hospital100
已完成
不适用
Efficacy and safety of ripasudil hydrochloride in glaucoma patients being treated by prostaglandin analogues, but their intraocular pressures are 15mmHg or under.glaucomaJPRN-UMIN000030742Yotsuya Shirato Ophthalmology Clinic30
尚未招募
不适用
Role of ripasudil eye drops in cataract surgeryCTRI/2021/02/031017Srikiran eye institute
已完成
不适用
Analysis of corneal endothelial dysfunctiocorneal endothelial dysfunctionJPRN-UMIN000046035Kawasaki Medical School24
已完成
不适用
Intraocular pressure-lowering effect of ripasudil hydrochloride hydrateJPRN-UMIN000044345Teikyo University School of Medicine100